These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3251774)

  • 1. Does high cortisol in uremic patients influence their glucagon levels?
    Ivić MA; Stefanović V
    Exp Clin Endocrinol; 1988 Aug; 91(3):362-4. PubMed ID: 3251774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol binding in uremic plasma. I. Absence of abnormal cortisol binding to cortisol binding to corticosteroid-binding globulin.
    Rosman PM; Benn R; Kay M; Tito J; Wallace EZ
    Nephron; 1984; 37(3):160-5. PubMed ID: 6738767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paper chromatography prior to cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure.
    Van Herle AJ; Birnbaum JA; Slomowitz LA; Mayes D; Chandler DW; Rosenblit PD; Nissenson A
    Nephron; 1998 Sep; 80(1):79-84. PubMed ID: 9730710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diurnal rhythm of cortisol and aldosterone plasma levels in patients with chronic renal insufficiency].
    Ivić MA; Micić M; Stefanović V
    Srp Arh Celok Lek; 1996; 124(5-6):115-9. PubMed ID: 9102829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-adrenocortical function in chronic renal failure: studies of episodic secretion of cortisol and dexamethasone suppressibility.
    Wallace EZ; Rosman P; Toshav N; Sacerdote A; Balthazar A
    J Clin Endocrinol Metab; 1980 Jan; 50(1):46-51. PubMed ID: 7350187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.
    Rosman PM; Benn R; Kay M; Wallace EZ
    Nephron; 1984; 37(4):229-31. PubMed ID: 6462312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglucagonaemia and renal failure.
    Matesanz R; Casado S; Valverde I; Hernando L
    Proc Eur Dial Transplant Assoc; 1977; 14():571-3. PubMed ID: 600972
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevations of gastrointestinal hormones in chronic renal failure.
    Doherty CC; Buchanan KD; Ardill J; McGeown MG
    Proc Eur Dial Transplant Assoc; 1978; 15():456-65. PubMed ID: 740678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of dialysis on plasma cortisol concentration in patients with renal failure].
    Szewczyk Z; Silber D; Skiba W; Checińska E; Szepietowski T; Kopeć W
    Pol Tyg Lek; 1975 Dec; 30(49):2037-40. PubMed ID: 1197088
    [No Abstract]   [Full Text] [Related]  

  • 12. ACTH and cortisol responses to glucagon stimulation.
    Waldhäusl W; Haydl H; Nowotny P
    J Clin Endocrinol Metab; 1976 Sep; 43(3):675-8. PubMed ID: 182712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
    Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O
    Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All products of proglucagon are elevated in plasma from uremic patients.
    Orskov C; Andreasen J; Holst JJ
    J Clin Endocrinol Metab; 1992 Feb; 74(2):379-84. PubMed ID: 1730817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
    Frank W; Rao TK; Manis T; Delano BG; Avram MM; Saxena AK; Carter AC; Friedman EA
    Trans Am Soc Artif Intern Organs; 1977; 23():59-64. PubMed ID: 910386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal counterregulation in ethanol-induced hypoglycemia-Glucagon and cortisol secretion in pigs.
    Tiengo A; Fedele D; Dolzani L; Ancona E; Muggeo M; Crepaldi G
    Horm Metab Res; 1976; Suppl 6():106-11. PubMed ID: 1278839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of haemodialysis session on plasma beta-endorphin, ACTH and cortisol in patients with end-stage renal disease.
    Letizia C; Mazzaferro S; De Ciocchis A; Cerci S; Morabito S; Cinotti GA; Scavo D
    Scand J Urol Nephrol; 1996 Oct; 30(5):399-402. PubMed ID: 8936630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergotamine alters plasma concentrations of glucagon, insulin, cortisol, and triiodothyronine in cows.
    Browning R; Gissendanner SJ; Wakefield T
    J Anim Sci; 2000 Mar; 78(3):690-8. PubMed ID: 10764077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate factor analysis of the high plasma concentration of cyclic AMP in patients with chronic renal failure.
    Marumo F; Sakai T; Shirataka M
    Int J Artif Organs; 1980 Jan; 3(1):18-22. PubMed ID: 6243611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.